You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《半日總結》恆指跌18點 藥股受壓 比亞迪逆市彈近8%
美長債孳息升至逾十六年高、內地上季經濟增長勝預期好淡因素抵銷,港股早市窄幅爭持。恆指低開45點,初段曾跌147點一度低見17,625點,在內地經濟數據公佈後曾倒升57點見17,831點,半日跌18點或0.1%,報17,755點;國指升1點或0.02%,報6,093點;恆生科技指數跌46點或1.2%,報3,789點。大市半日成交總額441.19億元,滬、深港通南下交易半日淨流出1.2億及淨流入2.78億元人民幣。 科技股方面,阿里(09988.HK)升0.1%報82.05元,騰訊(00700.HK)跌0.9%報299.6元,小米(01810.HK)升0.6%,美團(03690.HK)及網易(09999.HK)跌0.9%及1%。京東(09618.HK)及百度(09888.HK)跌3.2%及3.5%,快手(01024.HK)挫6.1%。此外,美圖(01357.HK)、心動(02400.HK)及阿里健康(00241.HK)各跌逾4%,中興(00763.HK)及聯想集團(00992.HK)跌5%及7.3%, 比亞迪系比亞迪電子(00285.HK)及比亞迪(01211.HK)分別發盈喜,比亞迪電子升3.4%,比亞迪升近8%報260元。中芯(00981.HK)升1.5%。花旗報告指,美擴大對華人工智能晶片出口限制,但無提進一步收緊DUV光刻機,料利好手機供應鏈。手機相關股富智康(02038.HK)及鴻騰(06088.HK)升4.5%及20%。 安踏(02020.HK)目標未來三年安踏品牌流水保持雙位數增長,FILA實現至少400億元流水,該股升2.3%報93元。其他消費股方面,潤啤(00291.HK)升2%,貓眼娛樂(01896.HK)跌2.5%。車股理想(02015.HK)及長汽(02333.HK)升2.9%及3.9%。 醫藥股受壓,藥明生物(02269.HK)跌4.7%,中生製藥(01177.HK)、中國中藥(00570.HK)、華潤醫藥(03320.HK)、信達生物(01801.HK)及康希諾(06185.HK)均跌逾2%。 金融股方面,匯控(00005.HK)升0.4%報62.1元,港交所(00388.HK)跌0.5%,友邦(01299.HK)升0.1%。內房股龍湖(00960.HK)及綠城中國(03900.HK)跌1.5%及2.3%,恆大(03333.HK)及旭輝(00884.HK)跌逾3%,碧桂園(02007.HK)再有境外債支付到期,該股半日升2.7%報0.75元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account